Skip to main content
Premium Trial:

Request an Annual Quote

At Large Scale Biology, Old President Returns to Become CEO

NEW YORK, April 14 - Large Scale Biology has appointed Kevin Ryan as its new president and CEO, replacing its current CEO, Robert Erwin, and former president, John Fowler, the company said today.

 

Erwin, a founder of LSBC, will remain as chairman of the board and head of the company's scientific advisory board. Fowler, who resigned as president, will remain on the LSBC board of directors through the current term and will join private investment firm Baycrest Capital.

 

"The appointment of Mr. Ryan, an executive with an outstanding record of general management, sales and marketing accomplishments, signals our commitment to move our unique technologies to market more rapidly," Erwin said in a statement.

 

This is Ryan's second term as an executive at LSBC. He served as president of the company from 1991 to 1995, and then left to become CEO of contact lens manufacturer Wesley Jessen Corporation.

 

In another management change, Ronald Artale, LSBC's senior vice president and chief financial officer will also take on the position of chief operating officer.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.